Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk

• Status: Unknown status
• Trial end date: 2021-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study was designed in order to evaluate and compare the efficacy and safety between aspirin and clopidogrel in the patient with low stroke risk Atrial Fibrillation (AF).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chuncheon Sacred Heart Hospital
• Treatments: Aspirin; Clopidogrel; Ticlopidine

Criteria

Inclusion Criteria:

1. Man or Women > 20 years old

2. newly detected AF (CHA2DS2VASc index score: 1)

3. Patient who needs antiplatelet therapy using aspirin clopidogrel for stroke prevention

4. volunteer only

5. childbearing aged women who takes proper oral contraceptive

Exclusion Criteria:

1. No specific contraindication or any history of hypersensitivity of Clopidogrel or aspirin

2. Patient with active GI bleeding or bleeding tendency or major bleeding history

3. less than 1 year of residual expected life

4. Pregnant or breast-feeding women

5. Other causes, determined by charged physician

6. Patient with definite GERD who needs special treatment

7. Patient who needs to take NSAID (Non-Steroidal Anti-Inflammatory Drug) for more than 2 weeks